The idea of unleashing the destructive powers of p53 inside cancer cells has become even more attractive after the realisation that p53 is controlled largely by a single master regulator, MDM2, which binds the tumour suppressor and negatively modulates its activity and stability. Here, TP53 is linked to neoplasm.